Phyton Biotech is the world leader in the application of plant cell culture technology for the commercial production of high value pharmaceuticals.

The R&D and manufacturing expertise in the company spans decades of small molecule and protein production experience.

Phyton owns and operates the world's largest cGMP plant cell culture facility with bioreactors up to 75,000 L in size and has

the only regulatory approved (in all major markets, including the US, Europe and Japan) plant cell culture process for the production of a pharmaceutical entity (paclitaxel for Bristol-Myers Squibb's TAXOL^®.